Salarius Pharmaceuticals ... (SLRX)
NASDAQ: SLRX
· Real-Time Price · USD
5.83
0.07 (1.22%)
At close: Aug 27, 2025, 1:23 PM
Salarius Pharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.5 | -0.18 | -0.3 | -0.48 | -0.23 | -0.3 | -0.73 | -0.25 | -0.26 | -0.21 | -0.14 | -0.19 | -0.6 | -0.76 | -1.37 | -3.07 | -3.86 | -6.13 |
PEG Ratio | 0.01 | 0.01 | -0.00 | 0.01 | 0.01 | -0.00 | 0.01 | 0.00 | 0.01 | -0.00 | 0.00 | -0.00 | 0.02 | -0.02 | -0.18 | -0.16 | -0.23 | -0.02 |
PS Ratio | n/a | n/a | 402.02 | n/a | n/a | n/a | 143.80 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 83.15 | 35.81 |
PB Ratio | -2.3 | 20.38 | 1.18 | 0.63 | 0.56 | 0.57 | 0.49 | 0.41 | 0.48 | 0.83 | 0.33 | 0.66 | 0.36 | 0.55 | 0.58 | 1.08 | 1.04 | 0.93 |
P/FCF Ratio | -2.22 | -1.07 | -2.4 | -1.37 | -1.24 | -1.54 | -1.7 | -0.66 | -0.92 | -1.45 | -0.73 | -1.92 | -3.11 | -3.69 | -8.28 | -29.03 | -14.97 | -16.69 |
P/OCF Ratio | -2.22 | -1.07 | -2.4 | -1.37 | -1.24 | -1.54 | -1.7 | -0.66 | -0.92 | -1.45 | -0.73 | -1.92 | -3.11 | -5.26 | -8.28 | -29.03 | -14.97 | -16.69 |
OCF/S Ratio | n/a | n/a | -167.76 | n/a | n/a | n/a | -84.46 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.56 | -2.15 |
Debt / Equity Ratio | n/a | 1.81 | 0.15 | 0.11 | n/a | 0.03 | 0.05 | 0.08 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 |
Quick Ratio | 0.92 | 1.01 | 1.98 | 4.09 | 2.98 | 3.91 | 5.02 | 3.59 | 3.28 | 2.33 | 3.40 | 5.78 | 8.31 | 11.88 | 14.29 | 21.82 | 24.73 | 20.94 |
Current Ratio | 0.92 | 1.01 | 1.98 | 4.09 | 2.98 | 3.91 | 5.02 | 3.59 | 3.28 | 2.21 | 3.40 | 5.78 | 8.31 | 11.88 | 14.29 | 21.82 | 24.66 | 20.94 |
Asset Turnover | n/a | n/a | 0.00 | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.01 | 0.02 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.45K |
Return on Equity | 1.15 | -27.63 | -0.97 | -0.33 | -0.6 | -0.47 | -0.17 | -0.4 | -0.46 | -0.96 | -0.61 | -0.87 | -0.15 | -0.18 | -0.11 | -0.09 | -0.07 | -0.04 |
Return on Assets | -0.69 | -0.73 | -0.48 | -0.25 | -0.4 | -0.35 | -0.13 | -0.29 | -0.32 | -0.53 | -0.43 | -0.73 | -0.14 | -0.17 | -0.1 | -0.08 | -0.06 | -0.04 |
Return on Invested Capital | 10.74 | -9.87 | -0.86 | -0.31 | -0.62 | -0.47 | -0.17 | -0.39 | -0.47 | -0.98 | -0.62 | -0.34 | -0.15 | -0.18 | -0.11 | -0.09 | -0.07 | -0.04 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | 0.50 | n/a | n/a | n/a | 0.94 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.67 | -0.37 |
Net Profit Margin | n/a | n/a | -330.76 | n/a | n/a | n/a | -49.28 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.38 | -1.46 |
Pretax Profit Margin | n/a | n/a | -330.76 | n/a | n/a | n/a | -49.28 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.38 | -1.46 |
Operating Profit Margin | n/a | n/a | -336.36 | n/a | n/a | n/a | -54.25 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.45 | -1.42 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | -336.11 | n/a | n/a | n/a | -54.19 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.45 | -1.42 |